H.B. Fuller outlines $650M-$675M FY2026 EBITDA range as it advances Advanced Medical Solutions acquisition (NYSE:FUL)
富乐富乐(US:FUL) Seeking Alpha·2026-06-26 02:33

技术访问问题 - 用户需在浏览器中启用Javascript和cookies以确保正常访问 [1] - 启用广告拦截器可能导致访问受阻，需禁用并刷新页面 [1]

H.B. Fuller outlines $650M-$675M FY2026 EBITDA range as it advances Advanced Medical Solutions acquisition (NYSE:FUL) - Reportify